Accretion Nutraveda Limited (BOM:544694)
345.00
-3.80 (-1.09%)
At close: Nov 16, 2026
Accretion Nutraveda Revenue
Accretion Nutraveda had revenue of 294.45M INR in the half year ending September 30, 2026. This brings the company's total for the last twelve months to 489.95M. In the fiscal year ending March 31, 2026, Accretion Nutraveda had annual revenue of 336.15M with 110.07% growth. That makes Accretion Nutraveda the 39,888th largest company in the world by revenue and 3,821st in India.
Revenue (ttm)
489.95M
Revenue Growth
+110.07%
P/S Ratio
5.10
Revenue / Employee
n/a
Employees
n/a
Market Cap
2.50B
Revenue by Geography
- India 334.84M 99.6%
- Export 1.20M 0.4%
Fiscal year ended Mar 31, 2026 See the full Accretion Nutraveda breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 336.15M | 176.13M | 110.07% |
| Mar 31, 2025 | 160.02M | 109.33M | 215.69% |
| Mar 31, 2024 | 50.69M | 20.66M | 68.81% |
| Mar 31, 2023 | 30.03M | 24.18M | 413.23% |
| Mar 31, 2022 | 5.85M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Aarey Drugs & Pharmaceuticals | 4.20B |
| Influx Healthtech | 1.65B |
| Resonance Specialties | 1.14B |
| Smruthi Organics | 1.12B |
| Panchsheel Organics | 1.10B |
| Kimia Biosciences | 1.04B |
| Tyche Industries | 503.78M |
| Himalaya Nutravedics India | 430.68M |